Bleeding Disorder Treatment Market Size, Trends, Industry Forecast 2032

Bleeding Disorder Treatment Market

Bleeding Disorder Treatment Market By Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others), By Drug Class (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytic, Fibrin Sealants, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2855 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 15.58 Billion USD 29.38 Billion 7.3% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global bleeding disorder treatment market, 2024-2032 (USD Billion)
    • 2.2. Global bleeding disorder treatment market: Snapshot
  • Chapter 3. Bleeding Disorder Treatment Market - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global bleeding disorder treatment market drivers: Impact analysis
      • 3.2.2. The increasing prevalence of bleeding disorders
      • 3.2.3. Government initiatives
      • 3.2.4. Technological advancements
    • 3.3. Market Restraints
      • 3.3.1. Global bleeding disorder treatment market restraints: Impact analysis
      • 3.3.2. Counterfeit treatments
      • 3.3.3. Reimbursement policies
      • 3.3.4. High treatment cost
    • 3.4. Opportunities
      • 3.4.1. R&D activities for the development of recombinant products
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by type
      • 3.6.2. Market attractiveness analysis, by drug class
      • 3.6.3. Market attractiveness analysis, by region
  • Chapter 4. Global Bleeding Disorder Treatment Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global bleeding disorder treatment market: company market share, 2024
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New material launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Bleeding Disorder Treatment Market - Type Analysis
    • 5.1. Global bleeding disorder treatment market: Type overview
      • 5.1.1. Global bleeding disorder treatment market revenue share, by type, 2024 and 2032
    • 5.2. Hemophilia A
      • 5.2.1. Global bleeding disorder treatment market for hemophilia A, 2024-2032 (USD Billion)
    • 5.3. Hemophilia B
      • 5.3.1. Global bleeding disorder treatment market for hemophilia B, 2024-2032 (USD Billion)
    • 5.4. Von Willebrand disease
      • 5.4.1. Global bleeding disorder treatment market for Von Willebrand disease, 2024-2032 (USD Billion)
    • 5.5. Others
      • 5.5.1. Global bleeding disorder treatment market for others, 2024-2032 (USD Billion)
  • Chapter 6. Global Bleeding Disorder Treatment Market - Drug Class Analysis
    • 6.1. Global bleeding disorder treatment market: Drug Class overview
      • 6.1.1. Global bleeding disorder treatment market revenue share, by drug class, 2024 and 2032
    • 6.2. Plasma-derived Coagulation Factor Concentrates
      • 6.2.1. Global bleeding disorder treatment market for plasma-derived coagulation factor concentrates pharmacies, 2024-2032 (USD Billion)
    • 6.3. Recombinant Coagulation Factor Concentrates
      • 6.3.1. Global bleeding disorder treatment market for recombinant coagulation factor concentrates, 2024-2032 (USD Billion)
    • 6.4. Desmopressin
      • 6.4.1. Global bleeding disorder treatment market for desmopressin, 2024-2032 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global bleeding disorder treatment market for others, 2024-2032 (USD Billion)
  • Chapter 7. Global Bleeding Disorder Treatment Market - Regional Analysis
    • 7.1. Global bleeding disorder treatment market: Regional overview
      • 7.1.1. Global bleeding disorder treatment market revenue share, by region, 2024 and 2032
    • 7.2. North America
      • 7.2.1. North America bleeding disorder treatment market, 2024-2032 (USD Billion)
      • 7.2.2. North America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
      • 7.2.3. North America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.2.4. The U.S.
        • 7.2.4.1. The U.S. bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.2.4.2. The U.S. bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.2.5. Canada
        • 7.2.5.1. Canada bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.2.5.2. Canada bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe bleeding disorder treatment market, 2024-2032 (USD Billion)
      • 7.3.2. Europe bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
      • 7.3.3. Europe bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. UK bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.3.4.2. UK bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.3.5. Germany
        • 7.3.5.1. Germany bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.3.5.2. Germany bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.3.6.2. France bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.3.7. Rest of Europe
        • 7.3.7.1. Rest of Europe bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.3.7.2. Rest of Europe bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific bleeding disorder treatment market, 2024-2032 (USD Billion)
      • 7.4.2. Asia Pacific bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
      • 7.4.3. Asia Pacific bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.4.4.2. China bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.4.5.2. Japan bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.4.6.2. India bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.4.7.2. Rest of Asia Pacific bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America bleeding disorder treatment market, 2024-2032 (USD Billion)
      • 7.5.2. Latin America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
      • 7.5.3. Latin America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.5.4. Brazil
        • 7.5.4.1. Brazil bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.5.4.2. Brazil bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
      • 7.5.5. Rest of Latin America
        • 7.5.5.1. Rest of Latin America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
        • 7.5.5.2. Rest of Latin America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa bleeding disorder treatment market, 2024-2032 (USD Billion)
      • 7.6.2. The Middle East and Africa bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
      • 7.6.3. The Middle East and Africa bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
  • Chapter 8. Company Profile
    • 8.1. CSL Behring
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Bayer AG
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Novo Nordisk
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Pfizer Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Shire PLC
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Grifols SA
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. Octapharma
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Amgen Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Cangene Corporation
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Developments
    • 8.10. Alnylam Pharmaceuticals
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global bleeding disorder treatment market revenue, 2024–2032 (USD Billion)
4. Porter’s Five Forces Analysis
5. Bleeding disorder treatment market attractiveness analysis, by type
6. Bleeding disorder treatment market attractiveness analysis, by drug class
7. Bleeding disorder treatment market: market attractiveness analysis, by region
8. Company market share analysis, 2024
9. Global bleeding disorder treatment market revenue share by type, 2024 and 2032
10. Global bleeding disorder treatment market for hemophilia A, 2024-2032 (USD Billion)
11. Global bleeding disorder treatment market for hemophilia B, 2024-2032 (USD Billion)
12. Global bleeding disorder treatment market for Von Willebrand Disease, 2024-2032 (USD Billion)
13. Global bleeding disorder treatment market for others, 2024-2032 (USD Billion)
14. Global bleeding disorder treatment market revenue share by drug class, 2024 and 2032
15. Global bleeding disorder treatment market for plasma-derived coagulation factor concentrates pharmacies, 2024-2032 (USD Billion)
16. Global bleeding disorder treatment market for recombinant coagulation factor concentrates, 2024-2032 (USD Billion)
17. Global bleeding disorder treatment market for desmopressin, 2024-2032 (USD Billion)
18. Global bleeding disorder treatment market for antifibrinolytic, 2024-2032 (USD Billion)
19. Global bleeding disorder treatment market for fibrin sealants, 2024-2032 (USD Billion)
20. Global bleeding disorder treatment market for others, 2024-2032 (USD Billion)
21. North America bleeding disorder treatment market, 2024-2032 (USD Billion)
22. Europe bleeding disorder treatment market, 2024-2032 (USD Billion)
23. Asia Pacific bleeding disorder treatment market, 2024-2032 (USD Billion)
24. Latin America bleeding disorder treatment market, 2024-2032 (USD Billion)
25. The Middle East and Africa bleeding disorder treatment market, 2024–2032 (USD Billion)


Table Of Tables

List of Tables

1. Global bleeding disorder treatment market: Market Snapshot 
2. Drivers of global bleeding disorder treatment market: Impact analysis 
3. Restraints of global bleeding disorder treatment market: Impact analysis  
4. North America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
5. North America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
6. The U.S. bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
7. The U.S. bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
8. Canada bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
9. Canada bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
10. Europe bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
11. Europe bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
12. UK bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
13. UK bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
14. Germany bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
15. Germany bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
16. France bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
17. France bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
18. Rest of Europe bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
19. Rest of Europe bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
20. Asia Pacific bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
21. Asia Pacific bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
22. China bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
23. China bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
24. Japan bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
25. Japan bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
26. India bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
27. India bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
28. Rest of Asia Pacific bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
29. Rest of Asia Pacific bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
30. Latin America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
31. Latin America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
32. Brazil bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
33. Brazil bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
34. Rest of Latin America bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
35. Rest of Latin America bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)
36. The Middle East and Africa bleeding disorder treatment market revenue, by type, 2024-2032 (USD Billion)
37. The Middle East and Africa bleeding disorder treatment market revenue, by drug class, 2024-2032 (USD Billion)

Methodology

FrequentlyAsked Questions

Bleeding disorder treatment focuses on managing excessive bleeding caused by deficiencies in blood clotting factors. Treatment methods vary depending on the severity and type of bleeding disorder.

According to a study, the global bleeding disorder treatment market size was worth around USD 15.58 billion in 2023 and is expected to reach USD 29.38 billion by 2032.

The global bleeding disorder treatment market is expected to grow at a CAGR of 7.3% during the forecast period.

North America is expected to dominate the bleeding disorder treatment market over the forecast period.

Leading players in the global bleeding disorder treatment market include Bayer AG, CSL Behring, Novo Nordisk, Pfizer Inc., Shire PLC, Grifols SA, Octapharma, Amgen Inc., Cangene Corporation, and Alnylam Pharmaceuticals, among others.

The bleeding disorder treatment market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

  • zion payment modes

List of Contents

Industry PerspectiveReport ScopeCompetitive Analysis

HappyClients